Gemcitabine accord 1000 mg RTU
Description: An antineoplastic (chemotherapy) medicine belonging to the group of “anti-metabolites” known as nucleoside metabolic inhibitors. It is a clear, colorless to pale yellow solution that works by slowing or stopping the growth of cancer cells.
Share Now
Additional Information
Product Name: Gemcitabine Accord 100 mg/ml concentrate
Active Ingredient: Gemcitabine (as gemcitabine hydrochloride).
Description: An antineoplastic (chemotherapy) medicine belonging to the group of “anti-metabolites” known as nucleoside metabolic inhibitors. It is a clear, colorless to pale yellow solution that works by slowing or stopping the growth of cancer cells.
Indication: Indicated for the treatment of several types of cancer:
- Bladder Cancer: In combination with cisplatin.
- Pancreatic Cancer: As a single agent or in combination therapy.
- Non-Small Cell Lung Cancer (NSCLC): Alone or in combination with cisplatin.
- Breast Cancer: In combination with paclitaxel for metastatic disease after failure of prior chemotherapy.
- Ovarian Cancer: In combination with carboplatin for advanced disease that has relapsed.
Strength: 100 mg/ml. (Available in various vial sizes, such as 200 mg/2 ml, 1000 mg/10 ml, 1500 mg/15 ml, and 2000 mg/20 ml).
Business Partner: Accord Healthcare
Related Products
Related products
Disclaimer
Pharma Solutions is the master distributor for the listed products in Egypt. The products are either registered and approved by the respective local health authority or contracted by the MAH to supply to the end users on a named patient basis. Some products such as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.